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Introduction
In this article, we present a rare case of 
angiomyolipoma (AML)-like lesion arising in nasal 
cavity with an unusual morphology.
Case Report
A 69-year-old Japanese man noticed the 
tumor on the anterior portion of the nasal cavity 
several years ago. As the size of the tumor 
gradually increased, he visited Department of 
Otolaryngology, our hospital. On the suspicion 
of benign tumor, the tumor was surgically 
resected. Macroscopically, the tumor measuring 
15x12mm was well-circumscribed and the cut 
surface of the tumor showed whitish color 
without necrosis or hemorrhage. Histologically, 
the tumor consisted of smooth muscle bundles 
closely adjancent to vascular structures and 
mature fat cells (Figure 1A, B). In the stroma, 
abundant mucin was identified and Alcian blue 
stain highlighted abundant mucin (Figure 1C). 
Immunohistochemically, smooth muscle cells 
were positive for alpha smooth muscle actin, but 
negative for Melanosome (HMB45), Melan A, S-100 
protein and TFE3. Ki-67 index was less than 1%. 
Vascular endothelial cells showed the positivity for 
CD31 and CD34. 
Discussion
The relationship between angioleiomyoma with 
adipose metaplasia and “so-called” mucocutaneous 
AML is debatable to date [1]. Actually, about 
sixteen cases of nasal cavity angioleiomyoma 
have been reported, and one case of vascular 
leiomyoma with abundant adipose cells has also 
been reported [2, 3]. However, it seems so difficult 
for pathologists to determine whether adipose 
tissue component shows neoplastic or metaplastic 
process. It is possible that these two concepts 
may show the sequential spectrum or be actually 
identical to each other. Accordingly, I made a 
conclusive diagnosis as AML-like lesion of the 
nasal cavity.
To the best of my knowledge, there are seven 
cases of nasal cavity “ so-called ” AML [4-10]. 
Clinicopathological features of these cases are 
summarized in Table 1. Most importantly, this 
disease is not associated with tuberous sclerosis 
clinically and has no expression for Melanosome 
(HMB45) immunohistochemically. Accordingly, “so-
called” AML of nasal cavity and skin essentially 
differs from that of other anatomic sites including 
kidney and liver. Because of this reason, the term 
of “mucocutaneous” AML has been previously 
proposed. Pathologists should pay attention in 
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making a final diagnosis because perivascular 
epithelioid cell tumor (PEComa) can occur in 
nasal cavity [10]. However, I propose the usage of 
another diagnostic term such as AML-like lesion, 
instead of AML, until the relationship between 
mucocutaneous AML and angioleiomyoma with 
adipose metaplasia will be clarified in order not 
to cause the confusion between “ true ” AML 
suggesting PEComa and mucocutaneous AML. In 
order to clarify the difference between true AML 
and mucocutaneous AML in clinical, pathologic and 
molecular genetic aspects, further investigations 
in a large scale study will be desirable in the 
future. Additionally, I found abundant stromal 
mucin deposition in this tumor. This finding was 
never previously described in AML-like lesion. 
Hence, stromal mucin deposition should be added 
in the histologic spectrum of nasal cavity AML-
like lesion, although myxoid change may be 
occasionally observed in angioleiomyoma. 
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Figure 1. Microscopic findings. (A) The lesion consists of smooth muscle cells, abortive vessels and mature fat 
cells. (B) The stroma contains abundant mucin. (C) Alcian blue stain highlights abundant stromal mucin deposition. 
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Table 1. Summary of previously reported angiomyolipoma (-like lesion) of the nasal cavity
Case Age, Sex TS Size (mm) Mucin HMB45 Follow-up (month) and outcome Reporter
1 52, M - 40 - - 12, AWOD Dawlatly
2 64, M - 20 - - 24, AWOD Gatalica
3 66, M - 20 - - 24, AWOD Watanabe
4 88, F - 20 - - 6, AWOD Watanabe
5 45, M - 15 - - 1, AWOD Tardío
6 52, M - 30 - - ? Erkiliç
7 54, M - ? - - ?, AWOD Moreira
8 69, M - 15 + - 2, AWOD Kuroda
M, male; F, female; TS, tuberous sclerosis, AWOD, alive without disease.
